International Biotechnology Trust PLC Amylyx Pharmaceuticals, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 295,000 shares of AMLX stock, worth $2.31 Million. This represents 1.83% of its overall portfolio holdings.
Number of Shares
295,000
Previous 25,000
1080.0%
Holding current value
$2.31 Million
Previous $539,000
902.04%
% of portfolio
1.83%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding AMLX
# of Institutions
153Shares Held
72.5MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$61.7 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$46.6 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$44.7 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$32.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$24.2 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $459M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...